Befejeződött1. fázis
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
Key facts
- Where
- Athens, GörögországSee the 2 sites
- Phase
- 1. fázis
Where in Görögország
- Alexandra HospitalAthens, GörögországNo longer taking part
- Evangelismos S AAthens, GörögországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaxosmithkline Research & Development Limited
- Trial code
- EU 2023-509915-10-00
- Record updated
- 2025. március 20.